Synthesis of L-chiro-inositol 1,4,6-trisphosphorothioate, a potent and selective inhibitor of myo-inositol 1,4,5-trisphosphate 5-phosphatase

Abstract L- chiro -inositol 1,4,6-trisphosphate and trisphosphorothioate have been synthesized from L-quebrachitol; the trisphosphorothiate is the most potent inhibitor of Ins(1,4,5)P 3 5-phosphatase yet discovered.

[1]  R. Huganir,et al.  Purified inositol 1,4,5-trisphosphate receptor mediates calcium flux in reconstituted lipid vesicles , 1989, Nature.

[2]  N. J. Noble,et al.  Total synthesis of myo-inositol-1-phosphate-4,5-pyrophosphate, a novel second messenger analogue, via myo-inositol-1-phosphate-4,5-bisphosphorothioate , 1992 .

[3]  S H Snyder,et al.  Solubilization, purification, and characterization of an inositol trisphosphate receptor. , 1988, The Journal of biological chemistry.

[4]  D. Clapham,et al.  Inositol 1,3,4,5-tetrakisphosphate activates an endothelial Ca2+-permeable channel , 1992, Nature.

[5]  Teiichi Furuichi,et al.  Primary structure and functional expression of the inositol 1,4,5-trisphosphate-binding protein P400 , 1989, Nature.

[6]  J. H. Boom,et al.  An expeditious synthesis of biological important myo-inositol phosphorothioates , 1991 .

[7]  A. Reitz.  Inositol phosphates and derivatives : synthesis, biochemistry, and therapeutic potential , 1991 .

[8]  T. Südhof,et al.  Structure and expression of the rat inositol 1,4,5-trisphosphate receptor. , 1990, The Journal of biological chemistry.

[9]  Michael J. Berridge,et al.  Inositol phosphates and cell signalling , 1989, Nature.

[10]  S. Nahorski.  Transmembrane signalling, intracellular messengers and implications for drug development , 1990 .

[11]  C. Downes,et al.  The inositol trisphosphate phosphomonoesterase of the human erythrocyte membrane. , 1982, The Biochemical journal.

[12]  R. Wojcikiewicz,et al.  Synthetic phosphorothioate-containing analogues of inositol 1,4,5-trisphosphate mobilize intracellular Ca2+ stores and interact differentially with inositol 1,4,5-trisphosphate 5-phosphatase and 3-kinase. , 1991, Molecular pharmacology.

[13]  M. Berridge,et al.  Inositol 1,4,5-trisphosphorothioate, a stable analogue of inositol trisphosphate which mobilizes intracellular calcium. , 1989, The Biochemical journal.

[14]  B. Potter,et al.  Molecular recognition of inositol polyphosphates by intracellular receptors and metabolic enzymes. , 1989, Trends in pharmacological sciences.

[15]  J. Huff,et al.  Metabolism of synthetic inositol trisphosphate analogs. , 1988, The Journal of biological chemistry.

[16]  B. Potter,et al.  myo‐Inositol 1,4,5‐trisphosphorothioate is a potent competitive inhibitor of human erythrocyte 5‐phosphatase , 1989, FEBS letters.

[17]  B. Potter,et al.  Myo-inositol(1,4,5)trisphosphorothioate binds to specific [3H]inositol(1,4,5)trisphosphate sites in rat cerebellum and is resistant to 5-phosphatase. , 1988, European journal of pharmacology.

[18]  B. Potter,et al.  Recent advances in the chemistry and biochemistry of inositol phosphates of biological interest. , 1990, Natural product reports.

[19]  M. Berridge,et al.  Inositol trisphosphate and diacylglycerol: two interacting second messengers. , 1987, Annual review of biochemistry.

[20]  B. Potter,et al.  3-position modification of myo-inositol 1,4,5-trisphosphate: consequences for intracellular Ca2+ mobilisation and enzyme recognition. , 1992, European journal of pharmacology.

[21]  B. Potter,et al.  Stereospecific mobilization of intracellular Ca2+ by inositol 1,4,5-triphosphate. Comparison with inositol 1,4,5-trisphosphorothioate and inositol 1,3,4-trisphosphate. , 1988, The Biochemical journal.